Shandong Sanyuan Biotechnology Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 227.48 million compared to CNY 447.84 million a year ago. Revenue was CNY 235.31 million compared to CNY 457.28 million a year ago.

Net income was CNY 33.32 million compared to CNY 119.18 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.61 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.61 a year ago.